All Downloads are FREE. Search and download functionalities are using the official Maven repository.

edits.seer.internal.rules.IFN2933.xml Maven / Gradle / Ivy

There is a newer version: 024-13
Show newest version
        <rule id="IFN2933" name="Serum Beta-2 Microglobulin Pretreatment Level, Schema ID, Required (NAACCR)" tag="N2933" java-path="lines.line" category="inter-field" depends="Year_of_Diagnosis">
            <expression><![CDATA[if (line.dateOfDiagnosisYear == null || line.dateOfDiagnosisYear < '2018' || line.schemaId == null || line.typeOfReportingSource == '7')
    return true
if (line.registryId == '0000001565' && line.dateOfDiagnosisYear > '2017' && line.dateOfDiagnosisYear < '2023')
    return true
if (line.registryId == '0000001566' && line.dateOfDiagnosisYear > '2017' && line.dateOfDiagnosisYear < '2022')
    return true

if (line.schemaId == '00821') {
    if (line.schemaDiscriminator1 == '0')
        return line.serumBeta2MicroglobulinPretxLvl != null && line.serumBeta2MicroglobulinPretxLvl != '5'
    else if (line.schemaDiscriminator1 == '1' || line.schemaDiscriminator1 == '9')
        return line.serumBeta2MicroglobulinPretxLvl == '5'
}

return true]]></expression>
            <message>Serum Beta-2 Microglobulin Pretreatment Level, Schema Discriminator 1 conflict for Myeloma</message>
            <description><![CDATA[1. The edit is skipped for any of the following conditions:
    a. Date of Diagnosis pre-2018, blank (unknown), or invalid.
    b. Schema ID is blank.
    c. Type of Reporting Source = 7 (Death Certificate Only)
    d. Registry ID = 0000001565 (Illinois) and Year of Diagnosis 2018-2022
    e. RegistryID = 0000001566 (Texas) and Year of Diagnosis = 2018-2021

2. This edit verifies that Serum Beta-2 Microglobulin Pretreatment Level is 
   coded (not blank) for the Schema IDs for which it is required by a standard 
   setter. Schema Discriminator 1 is required to identify a plasma cell myeloma 
   diagnosis eligible for RISS staging.

   This data item is required for AJCC staging and EOD Derived Stage Group.

   Required for Schema ID:

    00821: Plasma Cell Myeloma:
             If Schema Discriminator 1 = 0, Serum Beta-2 Microglobulin Pretreatment Level is not blank and not = 5.
             If Schema Discriminator 1 = 1 or 9, Serum Beta-2 Microglobulin Pretreatment Level must = 5.]]></description>
            <history>
                <event version="SE18-018-03" user="schadega" date="2018-07-17" ref="67906">Edit created.</event>
                <event version="SE18-018-05" user="schadega" date="2018-08-15" ref="68007">Added DCO skip condition.</event>
                <event version="SE18-018-06" user="kirbyk" date="2018-08-29" ref="68028">Serum Beta-2 Microglobulin Pretreatment Level must be blank if Schema Discriminator 1 is not = 0.</event>
                <event version="SE18-018-10" user="kirbyk" date="2018-11-30" ref="68058">Schema Discriminator 1 must not be blank for Schema ID 00821.</event>
                <event version="SE18-020-01" user="depryf" date="2020-02-04" ref="68281">Changed property names to align with NAACCR XML IDs.</event>
                <event version="SE21-021-09" user="beverung" date="2021-08-26" ref="68721">Add skip conditions for IL and TX for DX Years 2018-2020.</event>
                <event version="SE22-022-01" user="secristc" date="2022-01-28" ref="68859">Updated logic for schema ID 00821 to use code 5</event>
                <event version="SE22-022-03" user="secristc" date="2022-04-20" ref="68956">Change skip condition for IL to DX Years 2018-2022, and TX to 2018-2021</event>
            </history>
        </rule>




© 2015 - 2024 Weber Informatics LLC | Privacy Policy